Angelini Ventures
Italyangeliniventures.com
Overview
Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in BioTech and Digital Health. Angelini Ventures will invest €300 million across a global portfolio in Europe and North America, drawing on a global team, strategic advisors and partners to help entrepreneurs scale their businesses into transformative category-leading companies. The firm focuses on leveraging technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Handspring Health | Jul 2026 | Series B | Co-investor |
| COUR Pharmaceuticals | Jun 2026 | Series B | Co-investor |
| NUCLIDIUM AG | May 2026 | Series B Extension | Lead |
| Hypervision Surgical | Apr 2026 | Series A | Co-investor |
| Laigo Bio | Mar 2026 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
